Low levels of contaminant found in popular heartburn pills

Larry Davidson - September 14, 2019

On Friday, the US FDA announced that low amounts of chemicals linked to cancer have been discovered in the samples of Zantac, a heartburn medication.

The discovered chemical is a kind of impurity known as NDMA that has been related to an elevated risk for uterine and colorectal cancers.

According to the FDA, the low NDMA levels were discovered in the samples of a drug called ranitidine, which is utilized to prevent and treat heartburn by lowering stomach acid. It is sold in the country under the brand Zantac.

It isn’t known where the contamination really originated from. NDMA has previously also led to several blood pressure drug recalls last year.

Presently, the government hasn’t recalled Zantac or other medicines containing ranitidine.

The FDA informed that it is still analysing if the levels discovered in the antacids may have pose any health risk. Besides, it also said that people should stop consuming heartburn medication till the time more details are known.

The health officials from Europe said on Friday that they are also probing NDMA levels discovered in ranitidine.

The other heartburn medications in the market like Nexium, Prilosec and Prevacid comprise of distinct ingredients and aren’t included in this warning.

Larry D. is one of the most experienced writers at the Dork. His expert insights into the individual stocks have made small fortunes for some of his readers and profitable trades for many more. Best known for his work with under-the-radar growth stocks, Larry has been picking winners for over 30 years.

Leave a Reply

Your email address will not be published. Required fields are marked *